The US Supreme Court has said it will allow the abortion pill mifepristone to remain available while an appeal of the decision to strike down its regulatory approval make
Amgen has won a crunch appeals court ruling that delays generic competition to its big-selling psoriasis drug Otezla in the US until 2028, although it missed out on gettin
Johnson & Johnson posted a loss in the first three months of the year as it booked a massive $6.9 billion charge related to its recently-agreed proposal to settle clai
In the latest twist and turn of the rancorous abortion pill battle in the US, the Supreme Court has temporarily halted a lower court ruling that would have restricted acce
A federal appeals court has ruled that abortion drug mifepristone can remain available, but has blocked the drug from being sent to patients in the mail, along with other
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.